INMD
InMode LtdNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$835.51M
P/E Ratio
10.18
EPS
$1.35
Beta
1.98
52W High
$16.74
52W Low
$12.72
50-Day MA
$13.94
200-Day MA
$14.45
Dividend Yield
—
Profit Margin
23.30%
Forward P/E
10.17
PEG Ratio
2.90
About InMode Ltd
InMode Ltd. designs, develops, manufactures and markets minimally invasive aesthetic medical products based on its proprietary RF-assisted lipolysis and deep subdermal fractional RF technologies. The company is headquartered in Yokneam, Israel.
Fundamentals
| Revenue (TTM) | $374.64M |
| Gross Profit (TTM) | $291.61M |
| EBITDA | $80.52M |
| Operating Margin | 12.30% |
| Return on Equity | 13.60% |
| Return on Assets | 6.86% |
| Revenue/Share (TTM) | $5.92 |
| Book Value | $10.78 |
| Price-to-Book | 1.32 |
| Price-to-Sales (TTM) | 2.23 |
| EV/Revenue | 0.903 |
| EV/EBITDA | 4.20 |
| Quarterly Earnings Growth (YoY) | -30.80% |
| Quarterly Revenue Growth (YoY) | 5.30% |
| Shares Outstanding | $60.81M |
| Float | $53.89M |
| % Insiders | 11.91% |
| % Institutions | 54.68% |
Historical Volatility
HV 10-Day
17.19%
HV 20-Day
29.82%
HV 30-Day
27.54%
HV 60-Day
27.20%
HV Rank
20.6%
Volatility is currently contracting
Analyst Ratings
Consensus ($15.50 target)
1
Strong Buy5
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026